CTNM Reports $262.9M Cash, $15.2M Net Loss, Initiates IPF Trial, $93M Offering
Contineum Therapeutics, Inc. Class A Common Stock · PHARMACEUTICAL PREPARATIONS · Now $13.09
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS